Quidel | QDEL - Current Assets


Quidel reported $1.38B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Agilent USD 4.76B 148M Mar/2026
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Bruker USD 2.22B 121.4M Jun/2026
Cerus USD 174.38M 7.26M Dec/2025
Charles River Laboratories USD 1.53B 40.3M Jun/2026
Danaher USD 13.38B 554M Jun/2026
Haemonetics USD 810.83M 24.05M Jun/2026
Illumina USD 2.83B 96M Jun/2026
IQVIA Holdings USD 6.23B 6M Jun/2026
Merit Medical Systems USD 1.11B 10.46M Jun/2026
Mettler Toledo International USD 1.35B 15.48M Jun/2026
Myriad Genetics USD 289M 23.8M Jun/2026
Neogen USD 604.6M 14.6M Mar/2026
OraSure Technologies USD 240.78M 21.13M Mar/2026
Pacific Biosciences Of California USD 338.64M 30.88M Jun/2026
Quidel USD 1.38B 400K Jun/2026
Revvity USD 2.3B 169.4M Jun/2026
STAAR Surgical USD 312.4M 853K Mar/2026
Thermo Fisher Scientific USD 23.36B 1.05B Jun/2026
Waters USD 3.9B 186M Jun/2026